Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

Immunophenotyping of Blast Cells and Immune Effector Cells in Peripheral Whole Blood and Bone Marrow Samples From AML and MDS Patients (AML)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03801005
Recruitment Status : Recruiting
First Posted : January 11, 2019
Last Update Posted : February 11, 2019
Information provided by (Responsible Party):
Assistance Publique Hopitaux De Marseille

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 9, 2021
Estimated Study Completion Date : January 9, 2021